SIRT1 and prostate cancer: Second, Xiao et al. [18] and Zhou et al. [19] reported that melatonin treatment elevated the protein level of SIRT1 in clear cell renal cell carcinoma (ccRCC) (ccRCC) and prostate cancer (PCa).